Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,084 | 734 | 99.4% |
| Education | $65.99 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,470 | 120 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,339 | 104 | $0 (2024) |
| Lilly USA, LLC | $1,148 | 81 | $0 (2024) |
| ABBVIE INC. | $1,004 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $692.35 | 37 | $0 (2024) |
| PFIZER INC. | $544.72 | 35 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $517.42 | 31 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $379.18 | 23 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $358.91 | 21 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $313.13 | 22 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,743 | 95 | Novo Nordisk Inc ($305.67) |
| 2023 | $1,782 | 104 | AbbVie Inc. ($275.69) |
| 2022 | $1,627 | 101 | ABBVIE INC. ($243.38) |
| 2021 | $2,076 | 125 | AbbVie Inc. ($270.87) |
| 2020 | $1,279 | 96 | Novo Nordisk Inc ($228.82) |
| 2019 | $1,086 | 86 | GlaxoSmithKline, LLC. ($207.83) |
| 2018 | $830.78 | 70 | Novo Nordisk Inc ($210.53) |
| 2017 | $726.42 | 58 | GlaxoSmithKline, LLC. ($206.37) |
All Payment Transactions
735 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $13.39 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: Diabetes | ||||||
| 11/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Obesity | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: UROLOGY | ||||||
| 10/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Biological | ||||||
| 10/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: PAIN | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 957 | 1,767 | $218,336 | $109,825 |
| 2022 | 22 | 965 | 1,778 | $190,151 | $109,838 |
| 2021 | 26 | 1,165 | 2,179 | $226,922 | $132,472 |
| 2020 | 34 | 1,926 | 4,162 | $335,595 | $178,409 |
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 258 | $61,658 | $23,191 | 37.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 52 | 195 | $24,960 | $16,519 | 66.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 60 | $16,920 | $8,297 | 49.0% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 47 | 56 | $12,992 | $8,184 | 63.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 125 | $12,723 | $7,844 | 61.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 55 | 55 | $9,075 | $7,134 | 78.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 107 | $20,774 | $6,532 | 31.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 43 | 60 | $9,276 | $5,479 | 59.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 65 | 66 | $7,524 | $5,148 | 68.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 26 | 109 | $10,900 | $5,140 | 47.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 24 | 94 | $7,050 | $3,433 | 48.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 19 | 56 | $5,432 | $3,363 | 61.9% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 48 | 55 | $6,270 | $3,350 | 53.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $2,552 | $1,635 | 64.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,731 | $1,484 | 54.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 50 | 50 | $1,300 | $919.50 | 70.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 65 | $2,405 | $675.15 | 28.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 16 | 16 | $800.00 | $648.80 | 81.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 13 | 15 | $735.00 | $378.42 | 51.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 75 | 93 | $1,270 | $204.60 | 16.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $360.00 | $164.22 | 45.6% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 16 | 17 | $314.00 | $65.45 | 20.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 15 | $150.00 | $21.60 | 14.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 23 | 164 | $165.00 | $14.99 | 9.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 245 | $37,288 | $21,958 | 58.9% |
About Dr. Kajoor Sudhakara, MD
Dr. Kajoor Sudhakara, MD is a Internal Medicine healthcare provider based in Trenton, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295840734.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kajoor Sudhakara, MD has received a total of $11,150 in payments from pharmaceutical and medical device companies, with $1,743 received in 2024. These payments were reported across 735 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($11,084).
As a Medicare-enrolled provider, Sudhakara has provided services to 5,013 Medicare beneficiaries, totaling 9,886 services with total Medicare billing of $530,544. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Trenton, MI
- Active Since 08/21/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295840734
Products in Payments
- VRAYLAR (Drug) $764.37
- TRELEGY ELLIPTA (Drug) $712.05
- XARELTO (Drug) $488.68
- Ozempic (Drug) $438.06
- XIFAXAN (Drug) $370.61
- ENTRESTO (Drug) $364.18
- TRULICITY (Drug) $317.59
- Saxenda (Drug) $292.96
- JARDIANCE (Drug) $285.55
- ANORO (Drug) $271.95
- NURTEC ODT (Drug) $265.44
- ELIQUIS (Drug) $255.55
- UBRELVY (Drug) $248.30
- Victoza (Drug) $208.46
- VERQUVO (Drug) $201.85
- MOUNJARO (Drug) $199.90
- Vascepa (Drug) $194.52
- BASAGLAR (Drug) $189.12
- BREZTRI (Drug) $186.96
- SYMBICORT (Drug) $186.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Trenton
Dr. Jane Rohlf, Md, MD
Internal Medicine — Payments: $66,501
Dr. Edward Laub, M.d, M.D
Internal Medicine — Payments: $49,453
Sofia Mavasheva
Internal Medicine — Payments: $21,086
Dr. Anuj Chandra, M.d, M.D
Internal Medicine — Payments: $19,972
Iradj Sharim, M.d, M.D
Internal Medicine — Payments: $14,940
Nilesh Rana, Md, MD
Internal Medicine — Payments: $11,392